About Pan Drugs
Pan Drugs is a Healthcare company based in Vadodara (India) founded in 1979. It manufactures generic Active Pharmaceutical Ingredients and offers contract services worldwide. It operates on a B2B model. The company has 34 employees. Its Indian entity Pan Drugs Limited reported revenue of ₹1.12 Cr. Pan Drugs offers products and services including Active Pharmaceutical Ingredients and Custom Synthesis. Its focus areas include Pharmaceuticals, API Manufacturing, Generic APIs and Contract Manufacturing. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Pan Drugs Limited is a leading manufacturer of Active Pharmaceutical Ingredients, specializing in generic APIs through advanced process development and technical expertise. Based in Nandesari, Gujarat, India, the company operates with a global presence in countries like Bangladesh and Vietnam. It provides custom synthesis and contract manufacturing services, focusing on quality and innovation to meet international pharmaceutical demands while adhering to environmental standards.
- Headquarters Vadodara, India
- Employees 34
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website pandrugsltd.com
- Social X
- Legal Name Pan Drugs Limited
- Date of Incorporation 16 Nov, 1993
- Jurisdiction Vadodara, Gujarat, India
- Annual Revenue₹1.12 Cr
FY 2025 · -19% YoY
- Net Profit₹2.4 Lakh
FY 2025 · 2% margin
- EBITDA₹19.1 Lakh
FY 2025 · 17% margin
- Employee Count34
Associated legal entities of Pan Drugs
Pan Drugs operates through Pan Drugs Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Pan Drugs Limited CIN U24230GJ1993PLC020671 | Active | 16 Nov 1993 | Vadodara, Gujarat | ₹1.1 Cr | 34 | 5 | View details |
Products & Services of Pan Drugs
Pan Drugs offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients and Custom Synthesis.
Production of generic APIs for pharmaceutical applications.
Tailored synthesis services for client-specific needs.
Board of directors of Pan Drugs Limited (Pan Drugs)
Pan Drugs Limited is the primary company behind Pan Drugs. The board of Pan Drugs Limited currently have 5 directors; the longest-serving is Kamal Natwarlal Pandya, appointed in 1993. 10 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kamal Natwarlal Pandya DIN 01679134 | Director | 16 Nov 1993 | 32 yrs 11 mo | Pan Drugs Limited |
| Hemant Gajanand Upadhyay DIN 02907846 | Director | 31 May 2003 | 23 yrs 5 mo | Pan Drugs Limited |
| Atul Natwarlal Pandya DIN 01687035 | Director | 31 Jul 2007 | 19 yrs 3 mo | Pan Drugs Limited |
| Parag Vamanray Raval DIN 00533939 | Director | 10 May 2018 | 8 yrs 6 mo | Pan Drugs Limited |
| Rushiraj Atulbhai Pandya DIN 10991685 | Additional Director | 10 Mar 2025 | 1 yr 8 mo | Pan Drugs Limited |
Financials of Pan Drugs
Figures of Pan Drugs Limited, the primary company behind Pan Drugs, for FY 2025. Revenue was ₹1.12 Cr (-19% year on year). Net profit was ₹2.4 Lakh (2% margin). EBITDA was ₹19.1 Lakh (17% margin). Revenue has grown at a compounded annual rate of -77% over three years and -50% over five years.
- ₹1.12 CrRevenue · FY 2025 · -19% YoY
- ₹2.4 LakhNet profit · 2% margin
- ₹19.1 LakhEBITDA · 17% margin
- ₹3.14 CrPaid-up capital
- 34Employees (provident fund records)
- -77%Revenue CAGR, 3 years
- -50%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Pan Drugs Limited are on its company page.
Detailed financial statements for Pan Drugs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Pan Drugs
Pan Drugs has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Pan Drugs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pan Drugs
Pan Drugs was founded in 1979.
Pan Drugs is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.
Pan Drugs has 34 employees.
The primary company behind Pan Drugs, Pan Drugs Limited, reported revenue of ₹1.12 Cr for FY 2025, down 19% year on year.
Pan Drugs Limited is a leading manufacturer of Active Pharmaceutical Ingredients, specializing in generic APIs through advanced process development and technical expertise. Based in Nandesari, Gujarat, India, the company operates with a global presence in countries like Bangladesh and Vietnam. It provides custom synthesis and contract manufacturing services, focusing on quality and innovation to meet international pharmaceutical demands while adhering to environmental standards.
Pan Drugs's top competitors include Laurus Labs, Symbiotec and SeQuent.
Pan Drugs offers Active Pharmaceutical Ingredients and Custom Synthesis.
Pan Drugs operates through Pan Drugs Limited.
The legal entities of Pan Drugs currently have 5 directors, including Atul Natwarlal Pandya, Parag Vamanray Raval, Kamal Natwarlal Pandya and others.